Radiation for High-Risk Spine Metastases

This study is looking at whether Stereotactic Body Radiation Therapy (SBRT) to the spine can be used as the main treatment for certain cancers that have spread aggressively to the spine. The goal is to help patients avoid a large spine surgery. You might be able to join if you are 18 or older, have a solid tumor cancer that has spread to your bones (not your brain or spinal cord), and have spine involvement in up to three connected spinal bones. The study will measure how many people need spinal surgery or stabilization within 6 months after receiving SBRT. The current status of this study is unclear, and it plans to enroll 26 participants.

Study design
This is an interventional study with a planned enrollment of 26 participants. The phase of the study is not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will follow participants for 6 months to see if they need spinal surgery or stabilization.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06165419

Definitive Radiation for High-Risk Spine Metastases

Recruiting
PHASE2Ages 18+InterventionalTreatment
Stony Brook University
~26 participants
Updated 2025-05-14 on ClinicalTrials.gov
What's tested:SBRT to the spine

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cumulative incidence of spinal surgery/stabilization within 6 months following SBRT
Measured over 6 months
Metastatic Cancer
Metastatic Lung Cancer
Metastatic Breast Cancer
Metastatic Tumor
Metastatic Tumor of Bone
Metastatic Tumor to the Spine
Spine Metastases
Metastasis
1 sites across 1 states
New York1
  • Kartik Mani, MD PhD · PRINCIPAL_INVESTIGATOR · Stony Brook Cancer Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Cumulative incidence of spinal surgery/stabilization within 6 months following SBRT6 months

    Assess the efficacy of spine SBRT alone in controlling spine metastases